Cumberland Pharmaceuticals reports data from trial of ifetroban for DMD
US-based pharmaceutical company Cumberland Pharmaceuticals has reported positive top-line outcomes from a Phase II trial of ifetroban as a potential treatment for Duchenne muscular dystrophy (DMD). A total of 41 subjects with DMD were enrolled in the …